chronic myelogenous leukemia
Showing NaN - NaN of 13
CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)
Recruiting
- CML
- +3 more
- Asciminib add-on
- +3 more
-
Augusta, Georgia
- +46 more
Jan 23, 2023
Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)
Active, not recruiting
- Chronic Myelogenous Leukemia
-
Chicago, Illinois
- +87 more
Jan 20, 2023
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Biology of Long-Term Late Effects Following Hematopoietic Cell
Active, not recruiting
- Acute Lymphoblastic Leukemia/Lymphoma
- +4 more
-
Scottsdale, Arizona
- +31 more
Mar 8, 2022
Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)
Completed
- Chronic Myelogenous Leukemia
-
Fayetteville, Arkansas
- +22 more
Jun 29, 2021
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial
Completed
- Chronic Myelogenous Leukemia
- +3 more
-
Duarte, California
- +100 more
Jun 8, 2021
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
-
Tampa, Florida
- +11 more
Sep 3, 2020
Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/
Completed
- Acute Myeloid Leukemia
- +10 more
- fludarabine/busulfan
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago Medical Center
Oct 9, 2018
Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem
Completed
- Acute Myelogenous Leukemia
- +8 more
- Fludarabine
- +3 more
-
Chicago, IllinoisThe University of Chicago
Oct 7, 2016
Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))
Completed
- Chronic Myelogenous Leukemia
- imatinib mesilate
- +2 more
-
Birmingham, Alabama
- +162 more
Aug 7, 2013
Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- VCL-CB01
- Phosphate-buffered Saline (PBS)
-
Tucson, Arizona
- +21 more
Jul 31, 2013
Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)
Completed
- Chronic Myelogenous Leukemia
-
Birmingham, Alabama
- +69 more
Apr 13, 2011